Abstract:Background Immunoglobulin A vasculitis (IgAV), also named Henoch–Schönlein purpura, is a systemic vasculitis characterized by the deposition of IgA1-dominant immune complexes in small vessels that often involves the skin, joints, gastrointestinal tract, and kidney [1-3]. Research indicated increased frequencies of circulating activated B cells and plasmablasts in IgAV, which may serve as the source of the rising IgA levels [4]. T follicular helper (Tfh) 17 cells are considered to support the activation of B cells and help germinal center (GC) B cells switch to high-affinity IgA production. In human, Tfh17 cells prompt naive B cells to produce higher concentrations of IgA [5]. T cell-deficient mice that receive an adoptive transfer of Th17-Tfh cells show induced development of IgA-expressing GC B cells and an increase in the concentration of IgA. Transfer of non-Tfh17 phenotype CD4+ T cells leads to higher amounts of IgG in serum but fails to increase the serum IgA level [6]. Therefore, targeted therapy against Tfh17 cells may specifically inhibit the secretion of IgA and thereby ameliorate IgAV condition. Objectives Our previous study has confirmed that Tfh17 cells increase in the peripheral blood of IgAV patients [7]. However, there is no further study on the pathogenesis of IgAV. To evaluate the pathological role of Tfh17 cells in IgAV, we investigated the mechanism responsible for the differentiation of Tfh17 and the production of IgA in IgAV patients and IgAV rats respectively, and explored how to ameliorate IgAV by modulating Tfh17 generation. Methods Peripheral blood mononuclear cells from IgAV patients were analyzed by flow cytometry. In vitro culture was performed to assess the modulation of cytokine-induced phenotypes. IgAV rat model was established by intragastric administration of mixed solution, intraperitoneal injection of ovalbumin and Freund’s adjuvant. IgAV rats were used to explore the therapeutic effects of IL-6 blockade and the regulatory functions of IL-6 and TGF-β-producing dendritic cells in Tfh17 cells. Serum cytokine and IgA levels were measured by ELISA while histopathological changes were evaluated by H&E and PAS staining. Flow cytometry and immunofluorescence staining were used to detect T cell and GC B cell phenotypes in circulation and tissues of IgAV rats. Results Frequency of CD4+CXCR5+CCR6+ Tfh17 cells were increased in IgAV patients and associated with disease severity. IL-6 promoted the dendritic cell production of TGF-β and Tfh17 differentiation. Blockade of IL-6 signaling using tocilizumab inhibited Tfh17 differentiation, resulting in reduction of the germinal center and IgA production. Suppression of Tfh17 cells using IL-6 blockade greatly ameliorated clinical symptoms such as hemorrhagic rash and bloody stool and decreased IgA deposition and mesangial proliferation in the kidney in IgAV rats. Conclusion Our findings suggest that suppression of Tfh17 differentiation can alleviate IgA-mediated vasculitis and may permit the development of tailored medicines for treating IgAV. References [1]Davin JC, Coppo R. Henoch-Schönlein Purpura Nephritis in Children. Nat Rev Nephrol. 2014, 10 (10): 563-573. [2]Pillebout E, Sunderkötter C. IgA vasculitis. Semin Immunopathol. 2021, 43 (5): 729-738. [3]Thervet E, Pillebout E, Guillevin L, et al. Outcome after childhood Henoch-Schönlein purpura. Lancet. 2003, 361 (9351): 81. [4]Kawakami T, Watabe H, Mizoguchi M, et al. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein Purpura. Br J Dermatol. 2006, 155 (5): 983-987. [5]Morita R, Schmitt N, Bentebibel SE, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011, 34 (1): 108-121. [6]Hirota K, Turner JE, Villa M, et al. Plasticity of Th17 cells in Peyer’s patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol. 2013, 14 (4): 372-379. [7]Ma X, Nakayamada S, Wang J. Multi-Source Pathways of T Follicular Helper Cell Differentiation. Front Immunol. 2021, 12: 621105. Acknowledgements: NIL. Disclosure of Interests None Declared.

POS1442 AMELIORATION OF IGA VASCULITIS BY SUPPRESSION OF THE PATHOLOGICAL EXPANSION OF TFH17 CELLS

Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells

Follicular Helper T Cells in Peyer's Patches and Galactose- Deficient Iga1 Contribute to Iga Nephropathy

Pathogenesis of IgA Vasculitis: An Up-To-Date Review

Genome-wide studies define new genetic mechanisms of IgA vasculitis

IgA vasculitis with nephritis: an overview of the pathogenesis and clinical characteristic

Imbalance of Regulatory T Cells to Th17 Cells in IgA Nephropathy.

SAT0459 Low Dose IL-2 Restores Imbalance Between TH17 and Regulatory T Cells in Patients with Psoriatic Arthritis

TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.

Increased Proportion of Follicular Helper T Cells is Associated with B Cell Activation and Disease Severity in IgA Nephropathy.

Hirudin Ameliorates Immunoglobulin A Nephropathy by Inhibition of Fibrosis and Inflammatory Response

LPS/TLR4 Pathway Regulates IgA1 Secretion to Induce IgA Nephropathy

The transcription factor HMGB2 indirectly regulates APRIL expression and Gd-IgA1 production in patients with IgA nephropathy

Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF

Progression of IgA vasculitis with severe hematochezia during IFX treatment for pediatric Ulcerative Colitis: a case report and literature review

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis

Insight into the Interplay of Gd-IgA1, HMGB1, RAGE and PCDH1 in IgA Vasculitis (IgAV)

Increased Transforming Growth Factor-Beta (Tgf-Β)-secreting T Cells and IgA Anti-Cardiolipin Antibody Levels During Acute Stage of Childhood Henoch–Schönlein Purpura

Extracellular CIRP Co-Stimulated T Cells Through IL6R/STAT3 in Pediatric IgA Vasculitis

Inflammatory Cytokine-Neutralizing Antibody Treatment Prevented Increases in Follicular Helper T Cells and Follicular Regulatory T Cells in a Mouse Model of Arthritis.

Differentiation of T Helper 17 Cells May Mediate the Abnormal Humoral Immunity in IgA Nephropathy and Inflammatory Bowel Disease Based on Shared Genetic Effects